Notably, variations in the NOS1AP locus, which encodes nitric oxide synthase 1 adaptor protein, have emerged as prominent genetic modifiers of QTc (i.e., heart rate-corrected QT interval) prolongation and arrhythmic risk in the general population and in LQTS rare pathogenic variant carriers. The gene discussed is NOS1AP; the disease is familial long QT syndrome.